External Doctoral Candidate

Sara Gehder (formerly: Dühnen)

Room: D 3.014
Phone: +49 (0) 40 42878 4237
E-Mail: sara.gehder@tuhh.de

To arrange an appointment, please contact us by e-mail.

Curriculum vitae

01/2023 - Today PhD Student - Data Driven Innovation in Healthcare, Technische Universität Hamburg
01/2023 - Today Unternehmensentwicklung - Digital Office, Die Techniker Krankenkasse
02/2022 - 01/2023 Head of Business Development & Partnerships, Kry
02/2021 - 01/2022 Business Development, Kry
02/2019 - 12/2020 Consultant, Roland Berger
10/2018 - 12/2018 Intern Business Consulting, Bayer Business Services
04/2018 - 09/2018 Research Associate, Humboldt-Universität zu Berlin
08/2017 - 10/2017 Intern, Roland Berger
06/2016 - 07/2017 Freelancer - Technology Office Chemicals Science Relations, Merck KGaA
03/2016 - 06/2016 Intern Technology Office, Merck KGaG
07/2016 - 10/2016 Research Associate, Cornell University
2016 - 2018 Master of Science (M.Sc.) - Molecular Life Sciences, Humboldt-Universität zu Berlin
05/2015 - 12/2015 Research Associate, Universidad de los Andes, Bogotá
08/2014 - 10/2014 Research Internship, Freie Universität Berlin
2013 - 2016 Bachelor of Science (B.Sc.) - Biology, Freie Universität Berlin
2012 - 2014 Project Manager, LBBW
2009 - 2012 Bachelor of Arts (BA) - Business Administration, Duale Hochschule Baden-Württemberg

Research interests

Sara Gehder engages in research within the realm of innovations aimed at advancing the integration of patient-centered digital health applications into healthcare delivery. Her focus centers particularly on the innovative facets associated with the implementation of the Fast-Track Approval Process for Digital Health Applications (DiGA) established under the Digital Healthcare Act in Germany in 2019. Presently, her attention is directed towards broadening the conceptualization of efficacy to demonstrate the positive impact on care – transitioning from a sole emphasis on medical benefits to encompassing improvements in patient-relevant structures and procedures as potential catalysts for inclusion in statutory remuneration.
She aspires to gain a deeper understanding of why only a limited number of DiGA manufacturers have embraced this patient-centered gateway into statutory healthcare and is working on developing solutions to facilitate the future inclusion of more digital health applications with a distinct focus on patients in the provision of care.